So-Young International Inc.

What they do

So-Young International Inc. operates a platform for medical aesthetics services in China, connecting consumers with clinics and providing related services. The company also engages in the sale of medical products and maintenance services, and operates through multiple subsidiaries and variable interest entities. Its business includes online information services, reservation services, and medical treatment services.

Revenue drivers

• Information services — Revenue from medical aesthetics service providers for listing and promotional services on the platform; historically the largest revenue source.
• Reservation services — Fees from facilitating appointments between users and medical aesthetics clinics.
• Medical products and maintenance services — Sales of medical products and maintenance services, including through the Wuhan Miracle segment; a smaller but growing revenue line.
• Other services — Other ancillary services, including training and other offerings, representing a minor portion of total revenue.

Recent performance

Annual revenue peaked at $1.15 billion in 2019 but has since declined sharply, with no revenue figures reported for 2022-2025 in the available data. Net losses were reported for 2021 (-$1.3M), 2022 (-$9.5M), 2023 ($3.0M profit), 2024 (-$80.8M), and 2025 (-$34.6M). Operating cash flow was positive in 2021 ($13.2M) and 2023 ($3.2M) but negative in 2022 (-$16.4M), 2024 (-$3.5M), and 2025 (-$15.1M). As of December 31, 2025, total assets were $378.9 million, total liabilities $140.3 million, and shareholders' equity $222.1 million, with cash and equivalents of $59.8 million.

Strategy

Management's stated priorities include focusing on the core medical aesthetics platform, expanding medical products and maintenance services, and managing costs. The company has engaged in share repurchase programs, including a 2024 program, and continues to invest in technology and service offerings. Strategic initiatives may include exploring new revenue streams and optimizing operations to improve profitability.

Risks

• Regulatory risk — So-Young operates in China's highly regulated medical aesthetics and internet sectors, facing evolving rules on advertising, healthcare services, and data privacy.
• Revenue concentration — A significant portion of revenue historically comes from information services to medical aesthetics providers, making it vulnerable to sector downturns.
• Profitability concerns — The company reported net losses in four of the last five years, including a $80.8 million loss in 2024 and $34.6 million loss in 2025, raising going-concern questions.
• Cash flow pressure — Operating cash flow was negative in 2022, 2024, and 2025, indicating challenges in generating cash from operations.

Outlook

Management has not provided specific guidance in the available excerpts, but the company's recent filings highlight efforts to streamline operations and focus on core businesses. The outlook depends on stabilizing revenue and returning to profitability amid competitive and regulatory pressures in China's medical aesthetics market. Continued investment in medical products and maintenance services may be a key growth area.